These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29502924)

  • 41. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
    Biagi L; Hirata Bertachi A; Conget I; Quirós C; Giménez M; Ampudia-Blasco FJ; Rossetti P; Bondia J; Vehí J
    J Diabetes Sci Technol; 2017 Nov; 11(6):1089-1095. PubMed ID: 28633537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico Study.
    Campos-Náñez E; Breton MD
    J Diabetes Sci Technol; 2017 Nov; 11(6):1196-1206. PubMed ID: 28560900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of a reduced error range of SMBG in insulin-treated patients in Germany.
    Schnell O; Erbach M
    J Diabetes Sci Technol; 2014 May; 8(3):479-82. PubMed ID: 24876609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
    Peterson K
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
    [No Abstract]   [Full Text] [Related]  

  • 45. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of Continuous Glucose Monitoring During Three Closed-Loop Home Studies Under Free-Living Conditions.
    Thabit H; Leelarathna L; Wilinska ME; Elleri D; Allen JM; Lubina-Solomon A; Walkinshaw E; Stadler M; Choudhary P; Mader JK; Dellweg S; Benesch C; Pieber TR; Arnolds S; Heller SR; Amiel SA; Dunger D; Evans ML; Hovorka R
    Diabetes Technol Ther; 2015 Nov; 17(11):801-7. PubMed ID: 26241693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.
    Murata T; Aoki Y; Kato Y; Tanaka T; Araki R; Kato K; Hida K; Kawamura T; Yoshida K; Imamura Y; Toyonaga T; Yamada K; Sakane N;
    J Diabetes Sci Technol; 2017 Sep; 11(5):1055-1056. PubMed ID: 28859515
    [No Abstract]   [Full Text] [Related]  

  • 48. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
    Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
    Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of glycemic variability in continuous subcutaneous insulin infusion therapy in type 1 diabetes related to anthropometry and complication status.
    Mehdi SK; Hatfield E; Dornhorst A; Oliver NS
    J Diabetes Sci Technol; 2009 Sep; 3(5):1227-8. PubMed ID: 20144442
    [No Abstract]   [Full Text] [Related]  

  • 50. Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study.
    Elbalshy M; Boucher S; Crocket H; Galland B; MacKenzie C; de Bock MI; Jefferies C; Wiltshire E; Wheeler BJ
    J Diabetes Sci Technol; 2020 Sep; 14(5):844-853. PubMed ID: 31875411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple Post-Processing of Continuous Glucose Monitoring Measurements Improves Endpoints in Clinical Trials.
    Jensen MH; Dethlefsen C; Hejlesen O; Vestergaard P
    J Diabetes Sci Technol; 2020 Nov; 14(6):1074-1078. PubMed ID: 31096765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An alternative sensor-based method for glucose monitoring in children and young people with diabetes.
    Edge J; Acerini C; Campbell F; Hamilton-Shield J; Moudiotis C; Rahman S; Randell T; Smith A; Trevelyan N
    Arch Dis Child; 2017 Jun; 102(6):543-549. PubMed ID: 28137708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-time Continuous Glucose Monitoring During a Hyperinsulinemic-Hypoglycemic Clamp Significantly Underestimates the Degree of Hypoglycemia.
    Farrell CM; McNeilly AD; Hapca SM; McCrimmon RJ
    Diabetes Care; 2020 Oct; 43(10):e142-e143. PubMed ID: 32820010
    [No Abstract]   [Full Text] [Related]  

  • 55. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 56. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
    Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
    J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy.
    Kumareswaran K; Elleri D; Allen JM; Caldwell K; Nodale M; Wilinska ME; Amiel SA; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2013 Mar; 15(3):223-9. PubMed ID: 23445170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, May 3-5, 2012, Dublin, Ireland.
    Hoey H; Mlinac A; Tran CT; Schlaeger C
    Diabetes Technol Ther; 2012 Dec; 14(12):1155-73. PubMed ID: 23216339
    [No Abstract]   [Full Text] [Related]  

  • 59. A Head-to-Head Comparison Study of the First-Day Performance of Two Factory-Calibrated CGM Systems.
    Denham D
    J Diabetes Sci Technol; 2020 Mar; 14(2):493-495. PubMed ID: 31910661
    [No Abstract]   [Full Text] [Related]  

  • 60. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
    Rodbard D; Jovanovic L; Garg SK
    Diabetes Technol Ther; 2009 Dec; 11(12):757-65. PubMed ID: 20001676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.